@abc.net.au 4 years ago Second Australian blood clotting case developed two weeks after COVID vaccination, WA Health Minister says
@abc.net.au 4 years ago China's Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers
@WSJ 4 years ago A Covid-19 vaccine being developed by the University of Oxford and AstraZeneca showed a promising results in adults over 56, including the especially higher-risk age group of those 70 and older, according to an interim analysis on.wsj.com
@rt.com 5 years ago As Russia begins final stage of coronavirus vaccine trial, volunteers are confirmed to have immunity – and no side effects
@rt.com 4 years ago Pfizer says new trial data shows Covid vaccine ‘highly effective’ against South African strain
@WSJ 4 years ago The new coronavirus variant that is spreading across the U.K. could make it more difficult to reach so-called herd immunity, according to the chief executive of BioNTech, the German company that developed the Covid-19 vaccine with Pfizer on.wsj.com
@rt.com 4 years ago Access to Covid-19 vaccine means Russia could totally defeat coronavirus by next summer, according to creator of Sputnik V
@rt.com 5 years ago Russia to prepare 70 million doses of Covid-19 vaccine, lead scientist hopes it will provide immunity for more than 2 years
@nytimesworld 4 years ago The two-dose Covid-19 vaccine developed by Pfizer and BioNTech is protecting recipients about as well in wide actual use as it did in clinical trials, according to a new large-scale study from Israel. nyti.ms
@jezebel.com 4 years ago Woman Who Stayed In STEM Field Because She 'Needed the Income' Developed a Covid Vaccine
@inquisitr.com 4 years ago Russian COVID-19 Vaccine Appears To Work, Showing Success In Early Trials
@rt.com 4 years ago Dozens of people develop rare blood disorder after taking coronavirus vaccines – reports
@WSJ 4 years ago A Covid-19 vaccine being developed by the University of Oxford and AstraZeneca showed promising immune responses in elderly and older adults according to a just-published interim analysis previewed in late October on.wsj.com
@dailywire.com 4 years ago AstraZeneca Might Receive Emergency Use Authorization For Its Coronavirus Vaccine — In October: Report